News about Global Pharma

Indegene Achieves Revenue of INR 6,765 Million in First Quarter FY25

Indegene has announced its financial results, achieving revenue of INR 6,765 million in Q1FY25 with growth of 11.4 percent vs Q1FY24.

Global Pharma | 02/08/2024 | By Aishwarya |  416

Lupin Secures Approval from US FDA for Emtricitabine and Tenofovir Alafenamide Tablets

Lupin has received tentative approval from the United States Food and Drug Administration (US FDA) under the US President’s Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application for Emtricitabine and Tenofovir Alafenamide Tablets, 200 mg/25 mg.

Global Pharma | 01/08/2024 | By Aishwarya |  772

Rubicon Research Announces Filing of DRHP with SEBI

Rubicon Research Ltd. has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).

Global Pharma | 01/08/2024 | By Aishwarya |  1773

Waters Introduces New TA Instruments Rapid Screening-DSC for Antibody Drugs

Waters Corporation has launched the TA Instruments Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers.

Global Pharma | 31/07/2024 | By Aishwarya |  692

SSI Strategy to Leverage Metalmind AI Solutions to Enhance its Service Offerings

SSI Strategy has collaborated with MPS Metalmind AB, an innovator in AI services.

Global Pharma | 31/07/2024 | By Aishwarya |  489

Noze Secures New Funding for Disease Detection Technology

Noze has received a USD 5 million equity investment from the Bill and Melinda Gates Foundation.

Global Pharma | 31/07/2024 | By Aishwarya |  653

Sionna Signs License Agreement with AbbVie for Clinical Stage Compounds

Sionna Therapeutics has secured exclusive worldwide rights to develop and commercialize multiple clinical-stage compounds through a license agreement with AbbVie.

Global Pharma | 30/07/2024 | By Aishwarya |  520

Strides Pharma Shows Strong Q1FY25 Results with 16.7 Percent of Revenue Growth

Strides Pharma Science Ltd. has announced its consolidated financial results for the quarter (Q1FY25).

Global Pharma | 29/07/2024 | By Aishwarya |  678

Lifrblood Picks Brooks PathFinder System for Sample Management

Brooks Automation has been appointed as an official vendor for Lifeblood (Australian Red Cross Lifeblood), a global organization dedicated to the supply of blood and blood products.

Global Pharma | 29/07/2024 | By Aishwarya |  455

Acumen Announces New Findings from Phase 1 INTERCEPT-AD Study at AAIC 2024

Acumen Pharmaceuticals, Inc. has published new findings from its Phase 1 INTERCEPT-AD study of sabirnetug (ACU193).

Global Pharma | 29/07/2024 | By Aishwarya |  552